BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Thermo Fisher Scientific Declares Quarterly Dividend - May 21, 2025

  May 22, 2025

   · 

  1 min read
• Press Releases

  CEL-SCI Announces Proposed Public Offering - May 21, 2025

  May 22, 2025

   · 

  4 min read
• Press Releases

  Vaxart Announces Adjournment of Annual Meeting of Stockholders

  May 22, 2025

   · 

  6 min read
• Press Releases

  Lilly’s Kisunla (donanemab) receives marketing authorization in Australia for the treatment of early symptomatic Alzheimer’s disease

  May 22, 2025

   · 

  11 min read
• Press Releases

  CEL-SCI Announces Pricing of Public Offering - May 21, 2025

  May 22, 2025

   · 

  4 min read
• Press Releases

  Fourth NDA for Kelun-Biotech’s TROP2 ADC sacituzumab tirumotecan (sac-TMT) Accepted by the Center for Drug Evaluation

  May 22, 2025

   · 

  6 min read
• Press Releases

  Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011

  May 22, 2025

   · 

  4 min read
• Press Releases

  Atom Therapeutics Joins Gout Education Society on Gout Awareness Day, May 22, to Help Educate the Public on Risk Factors and Treatment Options for This Growing Disease

  May 22, 2025

   · 

  2 min read
• Press Releases

  Instil Bio and ImmuneOnco Announced the Phase 2 Trial in First-line NSCLC of IMM2510/AXN-2510 (‘2510), a PD-L1xVEGF Bispecific Antibody, in Combination with Chemotherapy in China is on Track to Complete Enrollment in Q3 2025; Initial Results Anticipated in 2H 2025

  May 22, 2025

   · 

  6 min read
• Press Releases

  Genflow Biosciences PLC Announces AGM Notice

  May 22, 2025

   · 

  2 min read